About Us
About us
Our Journey
16 May, 2013
My mother had significant macular degeneration. We treated her with anti-aging science and notice that she stopped progressing and did so for 15 years! Serendipity is finding something of value without looking for it. Two other patients with AMD also improved.
2015
A patient named Patty did not respond to multiple eye injections but did respond when put on the HOMING method. She no longer needs eye injections. Wow.
2017
In 2017, we studied using HOMING for migraines unresponsive to conventional therapies and had great success. We revisited our success with macular degeneration and felt it time to focus on the eye.
2021
In 2020, I studied 365 cases of eye disease and conducted research on them. In 2021, I conducted a test based on my research, and the results showed a recovery rate of 48% for dry AMD and 60% for wet AMD patients.
Our Journey
16 May, 2013
My mother had significant macular degeneration. We treated her with anti-aging science and notice that she stopped progressing and did so for 15 years! Serendipity is finding something of value without looking for it. Two other patients with AMD also improved.
2015
A patient named Patty did not respond to multiple eye injections but did respond when put on the HOMING method. She no longer needs eye injections. Wow.
2017
In 2017, we studied using HOMING for migraines unresponsive to conventional therapies and had great success. We revisited our success with macular degeneration and felt it time to focus on the eye.
2021
In 2020, we studied 365 eyes with dry or wet AMD and reaffirmed that our prior results were not a fluke. We published our results and are now spreading the word.
Our Team
George W. Rozakis, MD
Dr. Rozakis is a board certified biomedical engineer who studied medicine at Cornell Medical Center and studied Ophthalmology at the Duke Eye Center. Dr. Rozakis worked in the field of Advanced Wellness / Functional Medicine & The Optimization of Biochemistry for over 15 years. He has applied this science age-related chronic conditions. Dr. Rozakis won the advancements in healthcare award in Cleveland, Ohio (beating out the Cleveland Clinic) in 2015 for his work in Advanced Wellness and advocates for this approach to health care to his patients and colleagues.
Dr. Rozakis pioneered the field of Lasik refractive surgery, phakic refractive lenses, and the use of hormones and other advanced testing to treat macular degeneration, migraine, parkinson's, arthritis, insomnia, menopause, low testosterone, auto immune disease and other age-related chronic conditions.
George W. Rozakis, MD
Dr. Rozakis is a board certified biomedical engineer who studied medicine at Cornell Medical Center and studied Ophthalmology at the Duke Eye Center. Dr. Rozakis worked in the field of Advanced Wellness / Functional Medicine & The Optimization of Biochemistry for over 15 years. He has applied this science age-related chronic conditions. Dr. Rozakis won the advancements in healthcare award in Cleveland, Ohio (beating out the Cleveland Clinic) in 2015 for his work in Advanced Wellness and advocates for this approach to health care to his patients and colleagues.
Dr. Rozakis pioneered the field of Lasik refractive surgery, phakic refractive lenses, and the use of hormones and other advanced testing to treat macular degeneration, migraine, parkinson's, arthritis, insomnia, menopause, low testosterone, auto immune disease and other age-related chronic conditions.
Brian Bakke, Ph.D.
Dr. Bakke also holds a master’s degree in human nutrition from Columbia University. His master’s thesis work focused on studying the clinical nutrition practice patterns used by eye professionals in the prevention and treatment of Age-Related Macular Degeneration (AMD).
Prior to partnering with the Advanced Wellness Program through Investihealth, Dr. Bakke spent 6 years working as chief science officer with a medical consulting company. His work as chief science officer focused on collaborating with primary care physicians in developing personalized nutrition and bioidentical hormone based care plans for improving clinical outcomes for patients with complex medical conditions. Previously, Dr. Bakke spent 7 years working with the multi- national chemistry, biotechnology and life science companies BASF and Syngenta as a senior chemist.
Brian Bakke, Ph.D.
Dr. Bakke also holds a master’s degree in human nutrition from Columbia University. His master’s thesis work focused on studying the clinical nutrition practice patterns used by eye professionals in the prevention and treatment of Age-Related Macular Degeneration (AMD).
Prior to partnering with the Advanced Wellness Program through Investihealth, Dr. Bakke spent 6 years working as chief science officer with a medical consulting company. His work as chief science officer focused on collaborating with primary care physicians in developing personalized nutrition and bioidentical hormone based care plans for improving clinical outcomes for patients with complex medical conditions. Previously, Dr. Bakke spent 7 years working with the multi- national chemistry, biotechnology and life science companies BASF and Syngenta as a senior chemist.
In 2020, we conducted a study with 365 dry or wet AMD patients. We found that stability or improvement was possible for dry or wet AMD.
48% of dry AMD improved.
60% of wet AMD improved.
Literature Citation
More than 50% patients recovered
In 2013, We conducted a test with 365 dry and wet AMD patients. In this test recovery rate of patients is 48% of dry AMD and 60% of wet AMD. Another patient named Paddy, was suffering from dry AMD and temporary vision loss. Our strategies cured her and now she is living happily.
Small Call to Action Headline
The HOMING method has been a success in many clinical conditions indicating that addresses root causes of disease.
It won the Advancements in Health Care Award.
Had it not been for our success in many patients we may never have pursued macular degeneration.
We discuss the discovery process in our presentations.
Success: Strive, Thrive, and Shine
When it comes to achieving success, there are certain qualities that can help you reach your goals. Had it not been for our success in many patients we may never have pursued macular degeneration
What our patients say
Calvin K.
I am extremely pleased with the program. My eyesight has improved, especially my long distance vision for driving. I am able to drive at night!
Calvin K.
I am extremely pleased with the program. My eyesight has improved, especially my long distance vision for driving. I am able to drive at night!
Frequently Asked Questions
How long does it take to see improvements with dry AMD?
Our study followed patients for 6 months. Those who improved did so generally between 2 and 6 months. Unpublished data is showing that these effects are not lost out to 2-3 years and additional improvement is possible with more time. Time and compliance with the program are the keys to continued success.
Do I need to continue to take the program to sustain the benefits?
Similar to exercise and dietary practices, the favorable changes in your blood chemistry can only be sustained as long as you are taking your program.
Do Blood Tests Improve?
Yes. Consistently adhering to our program has led to marked improvements for our patients. It is the combination of time and unwavering commitment to the program that paves the way for enduring success.
How do you decrease the frequency of injections for Wet AMD.
This decision is made by you retina doctor. However it is reasonable to ask to decrease the time between injection if the OCT scans show no remaining fluid because the HOMING Method, according to scientific literature, may decrease the creation of growth factors in the eye (for which you are receiving the injections).
Is this Anti-Aging Medicine?
The Macular Program is a form of anti-aging medicine since macular degeneration is actually called AGE RELATED macular degeneration. Fighting aging is fighting AMD. What is nice is that treating AMD with HOMING also benefits other aging symptoms which is why we want to know about your eye AND General Health.
What would slow improvement in Dry or Wet AMD?
Age-Related Macular Degeneration (AMD), whether dry or wet, is a complex condition influenced by numerous factors. Our HOMING method helps to prevent, stabilize and even reverse macular degeneration.
What About GA?
Geographic Atrophy is a special form of dry macular degeneration that is felt to be caused by inflammation. The HOMING method reduces inflammation. Our clinical suspicion is that GA does not worsen if a patient is on the HOMING Method. This is an important matter because new drugs now exist to fight inflammation in eyes with GA, but these drugs need to be injected into the eye. We hope the HOMING method will allow patients to avoid eye injections for GA. The smart move is to be on the HOMING method and have the GA closely followed for progression. If no progression, then you don’t need shots. It’s your call.
New breakthrough allows age-related macular degeneration patients to improve vision and prevent further loss.
MacularProgram© 2023 | All Rights Reserved